Features of the Engraftment of Allogeneic Hematopoietic Stem Cells Using Reduced-Intensity Conditioning Regimens

Publisher Website
Google Scholar
Abstract
The features of the engraftment in 26 patients allografted using reduced-intensity conditioning regimen (8 with chronic myelogenous leukemia, 6 with acute myelogenous leukemia, 9 with acute lymphoblastic leukemia, 1 with hybrid acute leukemia, 1 with myelodysplasia and 1 with thalassemia major) were analyzed. Patients received a median of 10 × 108/Kg mononuclear cells (range 1.6 to 22.9), and a median of 4.2 × 106/Kg CD34 cells (range 0.3 to 14). There was a linear correlation between the number of infused mononuclear cells (MNC) and that of CD34 cells (r = 0.78, p = 0.002). Three patients (11%) failed to engraft; in those who engrafted, the median time to achieve >500 granulocytes was 11 days (range 10 to 22), and the median time to achieve >10 000 platelets was 12 days (range 10 to 41). The three patients who failed to engraft received less than 5 × 108/Kg MNC (1.6,4.6 and 4.9) and less than 0.5 × 106/Kg CD34; however, five of eight patients who received less than 5 × 108/Kg MNC still engrafted succesfully. On the other hand, all the patients who received less than 0.5 × 106/Kg CD34 cells failed to engraft. Within the group of patients who engrafted, it was found that those who received more than 7 × 106/Kg CD34+ cells tended to earlier recover > 20 × 109/L platelets (p = 0.02), and > 0.5 × 109/L neutrophils (p = 0.06) before day 15, than those who received less than 7 × 106/Kg CD34+ cells. No such association could be established between the number of MNC and the time for recovery. In these patients allografted using reduced-intensity conditioning regimens, the target doses of hematopoietic cell used were similar to those described for conventional allografts: The number of CD34 infused cells was significantly related to the possibility of failure to engraft and to the recovery rate of the hemopoiesis.

This publication has 11 references indexed in Scilit: